About Us

Contact Us

RCC
Home About Us Product News Order Career Contact

                                                                                                            

   

                                                                       Dapagliflozin

 

        Dapagliflozin is an experimental drug being studied by Bristol-Myers Squibb in partnership with AstraZeneca

        as a potential treatment for type 1 and 2 diabetes.


        CAS:461432-26-8


        Purity:>98.5%


        Single Impurity:<0.5%


       This product was researched by our company, produced since 2008, and can large-scale produced in 2009.

       We're the largest supplier of this product in China. And the quality beyond the international level.

 

 

 

Home About Us Product News Order Career Contact
 Copyright @ 2010-2011 APIs All rights reserved
 

 

 

No_Right_Click

 

No_Right_Click